Joint-Sponsorship Information:

This activity is jointly sponsored by Medical Education Collaborative, Inc. (MEC) and The Body PRO. For questions regarding the accreditation of this activity, please call MEC at (303) 420-3252.

For Physicians:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for continuing Medical Education through the joint sponsorship of Medical Education Collaborative, Inc. (MEC) and The Body PRO. MEC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Education Collaborative designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For Nurses:

Medical Education Collaborative (MEC) is the accredited provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

RNs, LPNs, LVNs and NPs can receive up to 1.0 contact hours for participation in this program. This program is cosponsored with Medical Education Collaborative, Inc. (MEC) and The Body PRO. Provider approved by the California Board of Registered Nursing, Provider Number CEP 12990, for 1.2 contact hour(s).

For Pharmacists:

1.0 contact hours (0.10 CEUs) of credit for pharmacists. Approval of this course for pharmacists is under a cosponsorship agreement between Medical Education Collaborative, Inc. (MEC) and The Body PRO. MEC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE #815-999-07-H02. The program is designed for all pharmacists.

Release Date: July 2, 2007. This activity is valid for credit through July 2, 2008.

Purpose Statement:

The purpose of this activity is to provide HIV physicians, pharmacists, nurses and other health care professionals with the opportunity to supplement their knowledge on issues related to the treatment of HIV-infected patients who are naive to antiretroviral therapy. This will be accomplished via a CME- and CE-accredited authoritative overview of strategies and considerations for initiating HAART in treatment-naive patients.

Target Audience:

This continuing-education activity has been developed for the educational benefit of physicians, nurses, pharmacists and other health care professionals involved in the clinical care of, or research efforts that impact the clinical care of, individuals with HIV.

Objectives:

Participants who complete this educational activity should be able to:

1. Identify key factors in assessing viable first-line regimens for HIV-infected patients.
2. Explain key components of the latest DHHS guidelines outlining the appropriate regimens with which to initiate antiretroviral therapy in HIV-infected patients.
3. Summarize the results of recent studies comparing the efficacy and safety of various antiretroviral regimens in HIV treatment-naive patients.
   

This activity is no longer available for CME/CE credit.